Ronaldo Rauseo-Ricupero focuses his litigation practice on defending corporations and individuals facing investigations by government entities and related complex civil actions. In addition to serving as a leader of the firm’s e-Discovery team, Ronaldo maintains an active pro bono practice with a focus on combating public corruption and assisting those facing deportation.
What do you focus on?
I focus on defending pharmaceutical and health care companies, defense contractors and other businesses and executives who are facing enforcement action under the False Claims Act, Anti-Kickback Statute, the Food Drug and Cosmetic Act and state consumer protection statutes. I have experience advising clients on matters at various stages—from internal investigation, to qui tam action, to civil or criminal enforcement, through follow-on litigation.
I have represented major national pharmaceutical companies in prominent federal and state investigations concerning product marketing and contracting practices, as well as state wholesale pricing cases; a major defense contractor in parallel civil and criminal investigations of billing practices from the Philadelphia United States Attorney’s Office; a health care industry executive targeted in an investigation of alleged off-label sales and kickback activities involving the Departments of Justice and Health and Human Services; multiple witnesses in a federal investigation of a prominent national skilled nursing facility service provider; a defendant in a federal investigation arising from Boston’s Big Dig construction project; and witnesses in a federal grand jury investigation of alleged federal campaign finance violations.
I also have a strong background in civil litigation and arbitration, including obtaining a multi-million dollar summary judgment for a municipality in a contract dispute; advising in a high-profile intellectual property licensing dispute before the federal district court in Connecticut; and representing a Canadian client before a 40-day multiparty arbitration session. In addition to successfully briefing matters in state and federal appellate courts, I recently argued and won a precedent-setting case before a federal circuit court of appeal.
What do you see on the horizon?
Growing trends indicate that government agencies are widening their intense enforcement scrutiny beyond the pharmaceutical industry, leading to heightened focus on medical device companies, durable medical equipment companies and skilled nursing facilities. These regulators and prosecutors are also increasingly attempting to pursue individual liability for executives, which will pose formidable compliance challenges for these sectors.
Mr. Rauseo-Ricupero was a major contributor to the recently published Massachusetts E-Discovery and Evidence.